Genetic screening services provided in Turkey

Journal of Genetic Counseling

Volumn 22, Issue 6, 2013, Pages 858-864

  Erdem, Yurdagül ^a   Tekşen, Fulya ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Autosomal reccesive diseases; Congenital anomalies; Consanguineous marriages; Genetic counseling; Genetic screening programs

Indexed keywords

ARTICLE; GENETIC SCREENING; HEALTH CARE DELIVERY; HUMAN; NEOPLASM; NEWBORN; NEWBORN SCREENING; ORGANIZATION AND MANAGEMENT; TURKEY (REPUBLIC); UTILIZATION REVIEW; VOCATIONAL EDUCATION;

DELIVERY OF HEALTH CARE; EDUCATION, PROFESSIONAL; GENETIC TESTING; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; NEOPLASMS; TURKEY;

EID: 84888135348     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-013-9644-9     Document Type: Conference Paper

References (62)

1. AdalI, T. (2008). Tempo Effects on Period Fertility in Turkey: A Study from Turkey Demographic and Health Surveys. Nüfusbilim Dergisi/Turkish Journal of Population Studies, 30-31: 43-54. Access from http://www.hips. hacettepe.edu.tr/nbd-cilt30-31/Adali.pdf. Dates: Jan 12, 2013.
2. Akdaǧ, R. (2011). Turkey Health Transformation Program Evaluation Report (2003-2010). Ministry of Health Press Number: 839. Access from http://www.sb.gov.tr/EN/belge/2-394/turkey-health-tranformation-program- evaluation-report-html. Date: July 12, 2012.
3. Anderson, O.B.; Yip, H.C.; Smith, A.R.; Shyyon, R.; Sener, F.C.; Eniu, A.; Carlson, W.R.; Azavedo, E.; Harford, J. (2007). Guideline implamentation for breast healthcare in low-income and middle-income countries. CANCER Supplement 113(8): 2221-2230. Access from http://screening.iarc.fr/doc/ Guideline%20implementation%20for%20breast%20healthcare%20in%20low- income%20and%20middle%20income%20countries.pdf. Date, May 19, 2013.
4. Antmen, B. (2009). Orak Hücre Anemisi (Sickle-Cell Anemia). Türk Pediatri Arşivi, 44, 39-42.
5. BaşIbüyük, A. (2004). The problem of rural development in Turkey in the view of geography. Eastern Geographical Review, 12, 45-65.
6. Baykal, T.; Huner, G.; Sarbat, G.; Demirkol, M. (1998). Incidence of biotinidase deficiency in Turkish newborns. Acta Paediatrics, 87(10), 1102-1103.
7. Berkman, C. C.; Dinç, H.; Sekeryapan, C.; Togan, I. (2008). Alu insertion polymorphisms and an assessment of the genetic contribution of central Asia to Anatolia with respect to the Balkans. American Journal of Physical Anthropology, 136(1), 11-18.
8. Çaǧlayan, S.; Kayhan, B.; Menteşoǧlu, S.; Aksit, S. (1989). Changing incidence of neural tube defects in Aegean Turkey. Paediatric and Perinatal Epidemiology, 3(1), 62-65.
9. Canatan, D.; Köse, M. R.; Üstündaǧ, M.; Haznedaroǧlu, D.; Özbaş, S. (2006). Hemoglobinopaty control programme in Turkey. Community Genetics, 9, 124-126.
10. Chang-Claude, J.; Eby, N.; Kiechle, M.; Bastert, G.; Becher, H. (2000). Breastfeeding and breast cancer risk by age 50 among women in Germany. Cancer Causes and Control, 11, 687-695.
11. Chipman, P. (2006). The moral implications of prenatal genetic testing. Penn Bioethics Journal, 2(ii), 13-16.
12. Control Programme of Hereditary Hematological Diseases (2002). Instructions of the Diagnosis and Treatment Centers in Turkey. Official Gazette Number: 24916.
13. Çürük, M. A.; Zeren, F.; Genç, A.; Aygün Ozavci, S.; KIlInç, Y.; Aksoy, K. (2008). Prenatal diagnosis of sickle cell anemia and Beta-thalessemia in Southern Turkey. Hemoglobin, 32(6), 525-530.
14. Doǧan, M.; Bay, A.; YIlmaz, C.; Köse, Y.; Açikgöz, M.; Çaksen, H. (2005). Biotinidaz Enzim Eksikliǧi: Üç VakanIn Sunumu. TIp AraştIrmalarI Dergisi, 3(3), 34-37.
15. Dursun, P.; Gültekin, M.; Yüce, K.; Ayhan, A. (2006). What is the underlying cause of aneuploidy associated with increasing maternal age? Is it associated with elevated levels of gonadotropins? Medical Hypotheses, 66(1), 143-147.
16. Egan, J. F.; Benn, P. A.; Zelop, C. M.; Bolnick, A.; Gianferrari, E.; Borgida, A. F. (2004). Down syndrome births in the United States from 1989 to 2001. American Journal of Obstetrics and Gynecology, 191, 1044-1048.
17. Family Planning Law (1983). (Nüfus PlanlamasI HakkInda Kanun). Official Gazette Number 18059.
18. Ferlay, J.; Autier, P.; Bonial, M.; Heanue, M.; Colombet, M.; Boyle, P. (2006). Estimated of the cancer incidence and mortality in Europe in 2006. Annals of Oncology. DOI: 10.1093/annonc/md1498. Access from http://www. brustkrebsfrueherkennung.info/html/img/pool/Estimates-of-the-cancer-incidence- and-mortality-in-Europe-in-2006.pdf. Date May 19, 2013.
19. Gökçümen, O. (2008). Ethnohistorical and Genetic Survey of Four Central Anatolian Settlements. Acsess from http://repository.upenn.edu/ dissertations/AAI3328565. July, 12, 2012.
20. Güvenç, H.; Uslu, M. A.; Güvenç, M.; Özekici, U.; Kocabay, K.; Bektaş, S. (1993). Changing trend of neural tube defects in eastern Turkey. Journal of Epidemiology Community Health, 47(1), 40-41.
21. Kuşkucu ÇInar, A. (2010). Fetal Kromozom Anomalisi Tarama Testleri (Fetal Chromosome Anomaly Screening Tests). Jinekoloji Obstetrik Pediatri Dergisi, 2(2), 55-60.
22. Lippman, A. (1994). The Genetic Construction of Prenatal Testing: Choice, Consent or Conformity for Women? In K. H. Rothman & E. J. Thomson (Eds.), Women and Prenatal Testing: Facing the Challenges of Genetic Technology (pp. 9-33). Columbus: Ohio State University Press.
23. Ministry of Health (1998). Maternal and Child Health Family Planning General Directory.
24. Ministry of Health (2010). Private Hospitals General Directory Genetic Diseases Diagnostic Centers Report.
25. National Breast Cancer Registry. (2008). Statistical analysis of National Breast Cancer Registry Program of Turkish Federation of Breast Societes 2008 Executive summary of the national cancer control programmes: policies and managerial guidelines.
26. National Breast Cancer Registry. (2012). Meme SaǧlIǧI (Breast Health). Acsess from, http://www.mdkk.org/memekanseri/register.php. Dates: July 1, 2012.
27. National Newborn Hearing Screening Programs. (2012). Access from http://sbu.saglik.gov.tr/IsitmeTaramasi/Login.aspx?ReturnUrl=%2fisitmetaramasi date, January 14, 2013.
28. Onrat, S. T.; Seyman, H.; Konuk, M. (2009). Incidence of Neural Tube Defects in Afyonkarahisar, Western Turkey. Genetic Molecular Research, 8(1), 154-161.
29. Özalp, I.; Coşkun, T.; TokatlI, A.; Kalkanoǧlu, H. S.; Dursun, A.; Tokol, S.; Köksal, G.; et al. (2001). Newborn PKU screening in Turkey: at present and organization for future. Turkish Journal of Pediatrics, 43(2), 97-101.
30. Özkinay, C. (2011). Genetic Counseling and Prenatal Diagnosis. Turkiye Klinikleri Journal of Pediatrics Sciences, 7(2), 116-122.
31. Özmen, V. (2008). Breast Cancer in the World and Turkey. The Journal of Breast Health, 4(2), 7-12.
32. Özmen, V.; ÖzçInar, B.; KaranlIk, H.; Cabioǧlu, N.; Tükenmez, M.; Dişçi, R.; Özmen, T.; et al. (2009). Breast cancer risk factors in Turkish women - a university hospital based nested case control study. World Journal of Surgical Oncology, 7, 37.
33. Öztürk, Y.; Erdur, B.; Tokgöz, Y. (2010). Clinical features of the patients with classic galactosemia. Turkiye Klinikleri Journal of Pediatrics, 19(1), 16-19.
34. Porter, P. (2008). "Westernizing" women's risks? Breast cancer in lower-income countries. The New England Journal of Medicine, 17, 213-216.
35. Regulation of Genetic Diseases Diagnostic Centers. (1998). Access from http://www.saglik.gov.tr/TR/belge/1-503/genetik-hastaliklar-tani-merkezleri- yonetmeligi.html. Date, June 12, 2013.
36. Reynolds, T. (2010). The triple test as a screening technique for down syndrome: reliability and relevance. International Journal of Women's Health, 2, 83-87.
37. Rodrigues-Cuevas, S.; Guisa-Hohustain, F.; Labastida-Almendora, S. (2009). First breast cancer mammography screening program in Mexico: initial results 2005-2006. Breast Journal, 15(6), 623-631.
38. Roizen, N. J.; Patterson, D. (2003). Down's syndrome. Lancet, 361, 1281-1289.
39. Sadak, M. (2012). Abortion. Access from http://www.turkhukuksitesi.com/ makale-974.html. Dates: July 13, 2012.
40. Shulman, N. L.; Willett, W.; Sievers, A.; Knaul, M. F. (2010). Breast cancer in developing countries: opportunities for improved survival. Journal of Oncology. doi: 10.1155/2010/595167.
41. Sivri AydIn, D.; Yayla, M. (2010). Türkiye Nüfus ve SaǧlIk AraştIrmasI SonuçlarInIn Antenatal BakIm, Fetal Perinatal ve Neonatal Prognoz Yönünden İrdelenmesi. Perinatoloji Dergisi, 18(3), 85-91.
42. Tekin, M. (2009). Genomic architecture of deafness in Turkey reflects Its rich past. International Journal of Modern Anthropology, 2, 39-51.
43. Tekin, M.; Duman, T.; Boǧoçlu, G.; Incesulu, A.; Comak, E.; Ilhan, I.; Akar, N. (2003). Spectrum Of GJB2 Mutations in Turkey comprises both caucasian and oriental variants: roles of parental consanguinity and assortative mating. Human Mutations, 21, 552-553.
44. Tekşen, F. (2000). The Investigation of couples whom admitted by spontaneous abortion. TIp SaǧlIk Dergisi, 4(4), 50-53.
45. Tekşen, F. (2002). The Concerns of a section of Moslem-Turkish women towards prenatal diagnosis. Journal of BWW Society, 3(1), 1-7.
46. Terzioǧlu, F. (2006). Anxiety of pregnant women after prenatal amniocentesis and genetic testing. In R. P. Sandra (Ed.), Focus on genetic screening research. New York: Nova.
47. Tfayli, A.;Temraz, S.; Abou Mrad, R.; Shamseddine, A. (2010). Breast cancer in low-and-middle-income countries: an emerging and challeging epidemic. Journal of Oncology. DOI: 10.1155/2010/490631. Access from http://www.hindawi. com/journals/jo/2010/490631/. Date May 19, 2013.
48. TomatIr, A. G. (2003). Genetik HastalIklardan Korunma. Sendrom, 15, 44-52.
49. TomatIr, A. G.; Sorkun, H. Ç.; Demirhan, H.; Akdaǧ, B. (2006a). Nurses' professed knowledge of genetics and genetic counseling. The Tohoku Journal of Experimental Medicine, 210(4), 321-332.
50. TomatIr, A. G.; Özşahin, A.; Sorkun, H. Ç.; Demirhan, H.; Akdaǧ, B. (2006b). Midwives' approach to genetic diseases and genetic counseling in Denizli, Turkey. Journal of Genetic Counseling, 15(3), 191-198.
51. TomatIr, A. G.; Sorkun, H. Ç.; Demirhan, H.; Akdaǧ, B. (2007). Genetics and genetic counselling: practices and opinions of primary care physicians in Turkey. Genetics in Medicine, 9(2), 130-135.
52. TomatIr, A. G.; Demirhan, H.; Sorkun, H. Ç.; Köksal, A.; Özerdem, F.; Çilengir, N. (2009). Major congenital anomalies: a five-year retrospective regional study in Turkey. Genetics and Moleculer Research, 8, 19-27.
53. TUIK, Population Statistics. (2011). Access from http://tuik.gov.tr/ VeriBilgi.do?tb-id=39&ust-id=11 date, December, 3, 2012
54. Tunçbilek, E.; Koç, I. (1994). Consanguineous marriage in Turkey and its impact on fertility and mortality. Annals of Human Genetics, 58(4), 321-329.
55. Tunçbilek, E.; Özgüç, M. (2007). Application of medical genetics in Turkey. Turkish Journal of Pediatrics, 49, 353-359.
56. Tunçbilek, E.; Boduroǧlu, K.; Alikaşifoǧlu, M. (1999). Results of the Turkish congenital malformation survey. Turkish Journal of Pediatrics, 41, 287-297.
57. Tuncer, M. (2008). Significance of cancer in Turkey, the burden of disease and cancer control policies. In M. Tuncer (Ed.), Cancer control in Turkey. Ankara: Onur Press.
58. Turkish Demographic and Health Survey. (2008). Hacettepe university Institute of population studies, ministry of health general directorate of mother and child health and family planning. Ankara: State Planning Organization and European Union.
59. WHO. (2005). 58th World Health Assembly Approved Resolution on Cancer Prevention and Control WHA58.22. Geneva, Switzerland.
60. WHO. (2006). Medical genetic services in developing countries: the ethical, legal and social Implications of genetic testing and screening. Cenevre: WHO.
61. Yardumian, A.; Schurr, T. G. (2011). Who are the Anatolian Turks? A reappraisal of the anthropological genetic evidence. Anthropology and Archeology of Eurasia, 50(1), 6-43.
62. Zheng, T.; Holford, T. R.; Mayne, S. T.; Owens, P. H.; Zhang, Y.; Zhang, B.; Boyle, P.; Zahm, S. H. (2001). Lactation and breast cancer risk: a case-control study in Connecticut. British Journal of Cancer, 84(11), 1472-1476.